OBJECTIVE: To assess factors that influence pulmonary function, because respiratory system dysfunction is common in chronic spinal cord injury (SCI). DESIGN: Cross-sectional cohort study. SETTING: Veterans Affairs Boston SCI service and the community. PARTICIPANTS: Between 1994 and 2003, 339 white men with chronic SCI completed a respiratory questionnaire and underwent spirometry. INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Forced expiratory volume in 1 second (FEV(1)), forced vital capacity (FVC), and FEV(1)/FVC. RESULTS: Adjusting for SCI level and completeness, FEV(1) (-21.0 mL/y; 95% confidence interval [CI], -26.3 to -15.7 mL/y) and FVC (-17.2 mL/y; 95% CI, -23.7 to -10.8 mL/y) declined with age. Lifetime cigarette use was also associated with a decrease in FEV(1) (-3.8 mL/pack-year; 95% CI, -6.5 to -1.1 mL/pack-year), and persistent wheeze and elevated body mass index were associated with a lower FEV(1)/FVC. A greater maximal inspiratory pressure (MIP) was associated with a greater FEV(1) and FVC. FEV(1) significantly decreased with injury duration (-6.1 mL/y; 95% CI, -11.7 to -0.6 mL/y), with the greatest decrement in the most neurologically impaired. The most neurologically impaired also had a greater FEV(1)/FVC, and their FEV(1) and FVC were less affected by age and smoking. CONCLUSIONS: Smoking, persistent wheeze, obesity, and MIP, in addition to SCI level and completeness, were significant determinants of pulmonary function. In SCI, FEV(1), FVC, and FEV(1)/FVC may be less sensitive to factors associated with change in airway size and not reliably detect the severity of airflow obstruction.
OBJECTIVE: To assess factors that influence pulmonary function, because respiratory system dysfunction is common in chronic spinal cord injury (SCI). DESIGN: Cross-sectional cohort study. SETTING:Veterans Affairs Boston SCI service and the community. PARTICIPANTS: Between 1994 and 2003, 339 white men with chronic SCI completed a respiratory questionnaire and underwent spirometry. INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Forced expiratory volume in 1 second (FEV(1)), forced vital capacity (FVC), and FEV(1)/FVC. RESULTS: Adjusting for SCI level and completeness, FEV(1) (-21.0 mL/y; 95% confidence interval [CI], -26.3 to -15.7 mL/y) and FVC (-17.2 mL/y; 95% CI, -23.7 to -10.8 mL/y) declined with age. Lifetime cigarette use was also associated with a decrease in FEV(1) (-3.8 mL/pack-year; 95% CI, -6.5 to -1.1 mL/pack-year), and persistent wheeze and elevated body mass index were associated with a lower FEV(1)/FVC. A greater maximal inspiratory pressure (MIP) was associated with a greater FEV(1) and FVC. FEV(1) significantly decreased with injury duration (-6.1 mL/y; 95% CI, -11.7 to -0.6 mL/y), with the greatest decrement in the most neurologically impaired. The most neurologically impaired also had a greater FEV(1)/FVC, and their FEV(1) and FVC were less affected by age and smoking. CONCLUSIONS: Smoking, persistent wheeze, obesity, and MIP, in addition to SCI level and completeness, were significant determinants of pulmonary function. In SCI, FEV(1), FVC, and FEV(1)/FVC may be less sensitive to factors associated with change in airway size and not reliably detect the severity of airflow obstruction.
Authors: F Pistelli; M Bottai; G Viegi; F Di Pede; L Carrozzi; S Baldacci; M Pedreschi; C Giuntini Journal: Am J Respir Crit Care Med Date: 2000-03 Impact factor: 21.405
Authors: Ann M Spungen; David R Grimm; Gregory Schilero; Roberta Lenner; Erwin Oei; William A Bauman; Peter L Almenoff; Marvin Lesser Journal: J Spinal Cord Med Date: 2002 Impact factor: 1.985
Authors: William S Linn; Ann M Spungen; Henry Gong; William A Bauman; Rodney H Adkins; Robert L Waters Journal: J Spinal Cord Med Date: 2003 Impact factor: 1.985
Authors: Daniela G L Terson de Paleville; William B McKay; Rodney J Folz; Alexander V Ovechkin Journal: Transl Stroke Res Date: 2011-12-01 Impact factor: 6.829
Authors: Bonnie E Legg Ditterline; Sevda C Aslan; David C Randall; Susan J Harkema; Camilo Castillo; Alexander V Ovechkin Journal: Arch Phys Med Rehabil Date: 2017-08-09 Impact factor: 3.966
Authors: Anthony C Waddimba; Nitin B Jain; Kelly Stolzmann; David R Gagnon; James F Burgess; Lewis E Kazis; Eric Garshick Journal: Arch Phys Med Rehabil Date: 2009-02 Impact factor: 3.966
Authors: Valery A Danilack; Kelly L Stolzmann; David R Gagnon; Robert Brown; Carlos G Tun; Leslie R Morse; Eric Garshick Journal: J Spinal Cord Med Date: 2013-11-26 Impact factor: 1.985
Authors: Kelly L Stolzmann; David R Gagnon; Robert Brown; Carlos G Tun; Eric Garshick Journal: Am J Respir Crit Care Med Date: 2008-01-17 Impact factor: 21.405
Authors: Evan L Stepp; Robert Brown; Carlos G Tun; David R Gagnon; Nitin B Jain; Eric Garshick Journal: Arch Phys Med Rehabil Date: 2008-08 Impact factor: 3.966
Authors: L R Morse; R A Battaglino; K L Stolzmann; L D Hallett; A Waddimba; D Gagnon; A A Lazzari; E Garshick Journal: Osteoporos Int Date: 2008-06-26 Impact factor: 4.507